Security Snapshot

Yarrow Bioscience, Inc. - common stock, par value $0.0001 (VYNE) Institutional Ownership

CUSIP: 92941V308

13F Institutional Holders and Ownership History from Q1 2023 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

42

Shares (Excl. Options)

13,158,548

Price

$0.60

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / common stock, par value $0.0001
Symbol
VYNE on Nasdaq
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
13,158,548
Latest holder snapshot 5 signals
Total 13F value
$7,861,042
Portfolio coverage rank
0%
Share change
+4,844,692
Value change
+$2,898,813
Number of holders
42
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
33,403,382
SEC-reported price per share
$0.68
Insider filing price
$0.68
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • VYNE - Yarrow Bioscience, Inc. - common stock, par value $0.0001 is tracked under CUSIP 92941V308.
  • 42 institutions reported positions in Q1 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 42 to 5 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $7,861,042 to $649,500.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 42 institutions filings for Q1 2026.

Open SEC evidence

Security key

92941V308

Latest holder period

Q1 2026

13F holders

42

13D/G owners

3

CIK / CUSIP context first

Open Q1 2026 holders VYNE full holder history VYNE Therapeutics Inc. SEC filings VYNE Therapeutics Inc. company facts VYNE Therapeutics Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
VYNE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Zhang Xiaofan 14% +137% $2,888,491 +$1,710,879 4,595,118 +145% Zhang Xiaofan 13 Jul 2026
Nantahala Capital Management, LLC 6% $1,195,000 2,000,000 Nantahala Capital Management, LLC 31 Mar 2026
CITADEL ADVISORS LLC 0% -103% $1,250 -$367,360 3,732 -100% Kenneth Griffin 30 Sep 2025

As of 31 Mar 2026, 42 institutional investors reported holding 13,158,548 shares of Yarrow Bioscience, Inc. - common stock, par value $0.0001 (VYNE). This represents 39% of the company’s total 33,403,382 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
39%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 6% 2,000,000 +100% 0.07% $1,195,000
Lynx1 Capital Management LP 4.9% 1,628,700 0.15% $973,148
Shay Capital LLC 4.8% 1,610,242 -0.87% 0.14% $962,120
Anson Funds Management LP 3.7% 1,243,106 -2.5% 0.1% $742,756
ADAR1 Capital Management, LLC 3.2% 1,063,899 +319% 0.04% $635,680
T3 Companies, LLC 2.8% 945,000 0% 0.77% $564,638
BRAIDWELL LP 2.7% 916,077 0.02% $547,356
CITADEL ADVISORS LLC 1.5% 514,443 +1585% 0% $307,380
KVP Capital Advisors, LP 1.5% 500,551 0% 0.22% $299,079
TWO SIGMA INVESTMENTS, LP 1.3% 426,412 +94% 0% $254,781
ACADIAN ASSET MANAGEMENT LLC 1.1% 381,797 -40% 0% $228,000
GEODE CAPITAL MANAGEMENT, LLC 0.97% 322,711 +43% 0% $192,824
Ikarian Capital, LLC 0.79% 264,912 0% 0.02% $158,284
VANGUARD CAPITAL MANAGEMENT LLC 0.79% 264,557 0% 0% $158,205
VANGUARD FIDUCIARY TRUST CO 0.55% 183,443 0% 0% $109,699
UBS Group AG 0.54% 179,784 +186% 0% $107,511
XTX Topco Ltd 0.47% 158,396 +100% 0% $94,642
Rangeley Capital, LLC 0.35% 118,064 +18% 0.08% $70,543
JANE STREET GROUP, LLC 0.29% 95,645 +32% 0% $57,148
BOOTHBAY FUND MANAGEMENT, LLC 0.24% 81,371 0% 0% $48,619
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.17% 57,784 -42% 0% $34,526
BlackRock, Inc. 0.13% 44,404 0% 0% $26,531
FNY Investment Advisers, LLC 0.1% 35,000 +40% 0.01% $20,000
HRT FINANCIAL LP 0.08% 27,569 0% $16,000
NORTHERN TRUST CORP 0.07% 23,110 0% 0% $13,808

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
14
Latest
Q1 2026
Rows shown
1-14 of 14
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 999,340 $649,500 +$1 $0.65 5
2026 Q1 13,158,548 $7,861,042 +$2,898,813 $0.60 42
2025 Q4 8,179,397 $4,743,526 +$1,869,192 $0.58 39
2025 Q3 3,924,005 $1,315,944 -$9,032,746 $0.34 31
2025 Q2 8,048,768 $13,279,291 +$1,503,898 $1.65 44
2025 Q1 7,109,939 $11,401,092 -$2,382,241 $1.58 36
2024 Q4 7,028,274 $23,320,995 +$606,162 $3.35 34
2024 Q3 7,312,555 $14,256,902 -$1,226,342 $1.88 31
2024 Q2 7,942,286 $16,030,293 +$243,077 $1.97 30
2024 Q1 6,405,086 $19,663,149 +$378,435 $3.07 29
2023 Q4 7,863,834 $18,322,345 +$17,207,859 $2.33 32
2023 Q3 360,099 $1,445,870 -$33,734 $4.04 20
2023 Q2 375,960 $1,532,386 +$198,131 $4.10 19
2023 Q1 335,259 $1,031,948 +$1,031,948 $3.08 19
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .